In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.

Pyronaridine, a Mannich base antimalarial, has demonstrated high in vivo and in vitro efficacy against chloroquine-resistant Plasmodium falciparum. Although this drug has the potential to become a prominent artemisinin combination therapy, little is known about its efficacy against drug-resistant Pl...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Price, R, Marfurt, J, Chalfein, F, Kenangalem, E, Piera, K, Tjitra, E, Anstey, N, Russell, B
Формат: Journal article
Хэл сонгох:English
Хэвлэсэн: 2010
_version_ 1826287977537470464
author Price, R
Marfurt, J
Chalfein, F
Kenangalem, E
Piera, K
Tjitra, E
Anstey, N
Russell, B
author_facet Price, R
Marfurt, J
Chalfein, F
Kenangalem, E
Piera, K
Tjitra, E
Anstey, N
Russell, B
author_sort Price, R
collection OXFORD
description Pyronaridine, a Mannich base antimalarial, has demonstrated high in vivo and in vitro efficacy against chloroquine-resistant Plasmodium falciparum. Although this drug has the potential to become a prominent artemisinin combination therapy, little is known about its efficacy against drug-resistant Plasmodium vivax. The in vitro antimalarial susceptibility of pyronaridine was assessed in multidrug-resistant P. vivax (n = 99) and P. falciparum (n = 90) isolates from Papua, Indonesia, using a schizont maturation assay. The median 50% inhibitory concentration (IC(50)) of pyronaridine was 1.92 nM (range, 0.24 to 13.8 nM) against P. falciparum and 2.58 nM (range, 0.13 to 43.6 nM) against P. vivax, with in vitro susceptibility correlating significantly with chloroquine, amodiaquine, and piperaquine (r(s) [Spearman's rank correlation coefficient] = 0.45 to 0.62; P < 0.001). P. falciparum parasites initially at trophozoite stage had higher IC(50)s of pyronaridine than those exposed at the ring stage (8.9 nM [range, 0.6 to 8.9 nM] versus 1.6 nM [range, 0.6 to 8.9 nM], respectively; P = 0.015), although this did not reach significance for P. vivax (4.7 nM [range, 1.4 to 18.7 nM] versus 2.5 nM [range, 1.4 to 15.6 nM], respectively; P = 0.085). The excellent in vitro efficacy of pyronaridine against both chloroquine-resistant P. vivax and P. falciparum highlights the suitability of the drug as a novel partner for artemisinin-based combination therapy in regions where the two species are coendemic.
first_indexed 2024-03-07T02:06:46Z
format Journal article
id oxford-uuid:9f45366a-d2dd-48e8-80c5-19c24a01d4fe
institution University of Oxford
language English
last_indexed 2024-03-07T02:06:46Z
publishDate 2010
record_format dspace
spelling oxford-uuid:9f45366a-d2dd-48e8-80c5-19c24a01d4fe2022-03-27T00:56:14ZIn vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9f45366a-d2dd-48e8-80c5-19c24a01d4feEnglishSymplectic Elements at Oxford2010Price, RMarfurt, JChalfein, FKenangalem, EPiera, KTjitra, EAnstey, NRussell, BPyronaridine, a Mannich base antimalarial, has demonstrated high in vivo and in vitro efficacy against chloroquine-resistant Plasmodium falciparum. Although this drug has the potential to become a prominent artemisinin combination therapy, little is known about its efficacy against drug-resistant Plasmodium vivax. The in vitro antimalarial susceptibility of pyronaridine was assessed in multidrug-resistant P. vivax (n = 99) and P. falciparum (n = 90) isolates from Papua, Indonesia, using a schizont maturation assay. The median 50% inhibitory concentration (IC(50)) of pyronaridine was 1.92 nM (range, 0.24 to 13.8 nM) against P. falciparum and 2.58 nM (range, 0.13 to 43.6 nM) against P. vivax, with in vitro susceptibility correlating significantly with chloroquine, amodiaquine, and piperaquine (r(s) [Spearman's rank correlation coefficient] = 0.45 to 0.62; P < 0.001). P. falciparum parasites initially at trophozoite stage had higher IC(50)s of pyronaridine than those exposed at the ring stage (8.9 nM [range, 0.6 to 8.9 nM] versus 1.6 nM [range, 0.6 to 8.9 nM], respectively; P = 0.015), although this did not reach significance for P. vivax (4.7 nM [range, 1.4 to 18.7 nM] versus 2.5 nM [range, 1.4 to 15.6 nM], respectively; P = 0.085). The excellent in vitro efficacy of pyronaridine against both chloroquine-resistant P. vivax and P. falciparum highlights the suitability of the drug as a novel partner for artemisinin-based combination therapy in regions where the two species are coendemic.
spellingShingle Price, R
Marfurt, J
Chalfein, F
Kenangalem, E
Piera, K
Tjitra, E
Anstey, N
Russell, B
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title_full In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title_fullStr In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title_full_unstemmed In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title_short In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
title_sort in vitro activity of pyronaridine against multidrug resistant plasmodium falciparum and plasmodium vivax
work_keys_str_mv AT pricer invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT marfurtj invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT chalfeinf invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT kenangaleme invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT pierak invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT tjitrae invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT ansteyn invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax
AT russellb invitroactivityofpyronaridineagainstmultidrugresistantplasmodiumfalciparumandplasmodiumvivax